Log In
Print
BCIQ
Print
Print this Print this
 

New-Fill

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionDermal filler
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationLipodystrophy
Indication DetailsTreat HIV-associated lipodystrophy
Regulatory Designation

Partner

Sinclair IS Pharma plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today